Fundz

Derm Biont, Inc. reported raising $8.79 Million in an initial SEC Form D filing, from an offering of $8.79 Million

PRIVATEJun 11, 2019

Amount Raised

$8.79 Million

$8.79 Million sold, per SEC Form D (first sale Jun 11, 2019)

Round Type

Venture

BostonBiotechnology

Quick answer

DermBiont raised $8.79 Million in a funding round, dated June 11, 2019. DermBiont is based in Boston, Massachusetts, United States.

How much did DermBiont raise?
DermBiont raised $8.79 Million in a funding round on June 11, 2019.
What does DermBiont do?
DermBiont’s mission is to become the world’s leading precision dermatology company developing and commercializing targeted topical therapeutics that treat, cure, and prevent diseases.
Where is DermBiont based and how big is it?
DermBiont is based in Boston, Massachusetts, United States.
Who are the decision-makers at DermBiont?
Fundz holds 1 contact at DermBiont, including the Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as DermBiont that raised within 45 days of this round, from Fundz verified event records.

  • TScan Therapeutics, Inc. raised $23M on July 26, 2019.
  • Delcath Systems raised $20M on July 25, 2019.
  • JUVA LIFE INC./Canada raised $74K (Pre-Seed) on July 24, 2019.
  • Korro Bio, Inc. raised $62M on July 23, 2019.
  • BlinkBio, Inc. raised $525K (Seed) on July 23, 2019.
  • Beta Bionics raised $63M on July 22, 2019.

Who to call at DermBiont, and when

A new round usually means DermBiont is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day DermBiont raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at DermBiont, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at DermBiont. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

DermBiont

Location

75 KNEELAND ST FL 14

Boston, Massachusetts, United States

About

DermBiont’s mission is to become the world’s leading precision dermatology company developing and commercializing targeted topical therapeutics that treat, cure, and prevent diseases. The company aims to impact the root causes of skin diseases through the development of targeted small molecule therapeutics with well-defined mechanisms of action and biotherapeutics that repair an imbalance of the microbiome. The company’s targeted topical therapeutics pipeline includes SM-020 for the treatment of seborrheic keratosis, SM-030 for the treatment of hyperpigmentation disorders of the skin, and DBI-001 & DBI-002 for the treatment of atopic dermatitis, tinea pedis, and onychomycosis.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment DermBiont raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsMax D., Executive OfficerSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for DermBiont's next move

See what Strategic adds

DermBiont raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.